Crispr Therapeutics Ag
Overview
Crispr Therapeutics AG is a pioneering biotechnology company focused on developing transformative gene-based medicines using its proprietary CRISPR/Cas9 platform. The company aims to cure a wide array of serious diseases, with a current focus on hemoglobinopathies, immuno-oncology, regenerative medicine, and rare diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Crispr Therapeutics Ag in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.